HIV infections has been the subject of sustained clinical investigation across multiple research sites.

103 total trials for this combination

Showing top 10 of 103 trials

Trials

NCT ID	Title	Status	Phase
NCT00062660	Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection	APPROVED_FOR_MARKETING	—
NCT06248190	ENHANCE-EvideNce Led Co-created HeAlth Systems interventioNs for MLTCs CarE	COMPLETED	NA
NCT03299049	Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults	ACTIVE_NOT_RECRUITING	PHASE3
NCT02362503	Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients	ACTIVE_NOT_RECRUITING	PHASE3
NCT00917904	An Expanded Safety Study of Dapivirine Gel 4789 in Africa	COMPLETED	PHASE1/PHASE2
NCT00561925	VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients	COMPLETED	PHASE3
NCT02951052	Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults	ACTIVE_NOT_RECRUITING	PHASE3
NCT00540449	TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.	COMPLETED	PHASE3
NCT00543725	TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors	COMPLETED	PHASE3
NCT00013897	A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine	COMPLETED	PHASE3

Related Pages

All HIV infections trials All trials in Cape Town, South Africa